167 related articles for article (PubMed ID: 19098684)
1. The APRI and the RVR.
Snyder N; Petersen JR
J Clin Gastroenterol; 2009; 43(5):500-1. PubMed ID: 19098684
[No Abstract] [Full Text] [Related]
2. The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C.
Le Calvez S; Thabut D; Messous D; Munteanu M; Ratziu V; Imbert-Bismut F; Poynard T
Hepatology; 2004 Mar; 39(3):862-3; author reply 863. PubMed ID: 14999708
[No Abstract] [Full Text] [Related]
3. Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C.
Vergniol J; Foucher J; Terrebonne E; Bernard PH; le Bail B; Merrouche W; Couzigou P; de Ledinghen V
Gastroenterology; 2011 Jun; 140(7):1970-9, 1979.e1-3. PubMed ID: 21376047
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive assessment of liver fibrosis: time to move from cross-sectional studies to longitudinal ones.
Kim SU; Han KH; Ahn SH
J Gastroenterol Hepatol; 2010 Sep; 25(9):1472-3. PubMed ID: 20796140
[No Abstract] [Full Text] [Related]
5. The utility of aspartate aminotransferase/platelet ratio index in HIV/hepatitis C-co-infected patients.
Shastry L; Wilson T; Lascher S; Nord JA
AIDS; 2007 Nov; 21(18):2541-3. PubMed ID: 18025895
[TBL] [Abstract][Full Text] [Related]
6. Use of AST platelet ratio index (APRI Score) as an alternative to liver biopsy for treatment indication in chronic hepatitis C.
Borsoi Viana MS; Takei K; Collarile Yamaguti DC; Guz B; Strauss E
Ann Hepatol; 2009; 8(1):26-31. PubMed ID: 19221530
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of HCV treatment: who does well and who does not?
Hsu CS; Kao JH
J Gastroenterol Hepatol; 2010 May; 25(5):846-8. PubMed ID: 20546434
[No Abstract] [Full Text] [Related]
8. Optimized cutoffs improve performance of the aspartate aminotransferase to platelet ratio index for predicting significant liver fibrosis in human immunodeficiency virus/hepatitis C virus co-infection.
Carvalho-Filho RJ; Schiavon LL; Narciso-Schiavon JL; Sampaio JP; Lanzoni VP; Ferraz ML; Silva AE
Liver Int; 2008 Apr; 28(4):486-93. PubMed ID: 18339075
[TBL] [Abstract][Full Text] [Related]
9. PAHA model: an alternative non-invasive predictor of liver cirrhosis in patients with chronic hepatitis B infection.
Ayonrinde OT; Olynyk JK
J Gastroenterol Hepatol; 2010 Jan; 25(1):3-4. PubMed ID: 20136968
[No Abstract] [Full Text] [Related]
10. Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.
Castéra L; Le Bail B; Roudot-Thoraval F; Bernard PH; Foucher J; Merrouche W; Couzigou P; de Lédinghen V
J Hepatol; 2009 Jan; 50(1):59-68. PubMed ID: 19013661
[TBL] [Abstract][Full Text] [Related]
11. Serum aminotransferase levels instead of etiology affects the accuracy of transient elastography in chronic viral hepatitis patients.
Cho HJ; Seo YS; Lee KG; Hyun JJ; An H; Keum B; Kim JH; Yim HJ; Jeen YT; Lee HS; Chun HJ; Um SH; Kim CD; Ryu HS
J Gastroenterol Hepatol; 2011 Mar; 26(3):492-500. PubMed ID: 21332545
[TBL] [Abstract][Full Text] [Related]
12. Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
Cheung RC; Currie S; Shen H; Bini EJ; Ho SB; Anand BS; Hu KQ; Wright TL; Morgan TR;
J Clin Gastroenterol; 2008 Aug; 42(7):827-34. PubMed ID: 18285716
[TBL] [Abstract][Full Text] [Related]
13. Noninvasive diagnosis of cirrhosis in chronic hepatitis C based on standard laboratory tests.
Lackner C; Struber G; Bankuti C; Bauer B; Stauber RE
Hepatology; 2006 Feb; 43(2):378-9; author reply 379. PubMed ID: 16440344
[No Abstract] [Full Text] [Related]
14. Noninvasive models to predict liver cirrhosis in patients with chronic hepatitis B.
Kim BK; Kim SA; Park YN; Cheong JY; Kim HS; Park JY; Cho SW; Han KH; Chon CY; Moon YM; Ahn SH
Liver Int; 2007 Sep; 27(7):969-76. PubMed ID: 17696936
[TBL] [Abstract][Full Text] [Related]
15. Liver fibrosis evaluation by ARFI and APRI in chronic hepatitis C.
Li SM; Li GX; Fu DM; Wang Y; Dang LQ
World J Gastroenterol; 2014 Jul; 20(28):9528-33. PubMed ID: 25071348
[TBL] [Abstract][Full Text] [Related]
16. External validation of biochemical indices for noninvasive evaluation of liver fibrosis in HCV chronic hepatitis.
Iacobellis A; Mangia A; Leandro G; Clemente R; Festa V; Attino V; Ricciardi R; Giacobbe A; Facciorusso D; Andriulli A
Am J Gastroenterol; 2005 Apr; 100(4):868-73. PubMed ID: 15784034
[No Abstract] [Full Text] [Related]
17. APRI-M6 for predicting long-term outcome of chronic hepatitis C patients after interferon-based therapy: more questions than answers.
Su TH; Kao JH; Chen DS
Hepatology; 2007 Jun; 45(6):1586-7; author reply 1587-8. PubMed ID: 17538939
[No Abstract] [Full Text] [Related]
18. A simple noninvasive index (APRI) predicts advanced liver fibrosis in children with chronic hepatitis B.
Lebensztejn DM; Skiba E; Sobaniec-Lotowska M; Kaczmarski M
Hepatology; 2005 Jun; 41(6):1434-5. PubMed ID: 15915470
[No Abstract] [Full Text] [Related]
19. FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C.
Morra R; Lebray P; Ingiliz P; Ngo Y; Munteanu M; Ratziu V; Poynard T
Hepatology; 2008 Jan; 47(1):353-4; author reply 354-6. PubMed ID: 18161711
[No Abstract] [Full Text] [Related]
20. [Utility of 2 biochemical models predictive of liver fibrosis grade in prison inmates with hepatitis C].
Portilla J; López-Burgos A; Saiz-De-La-Hoya-Zamácola P; Sánchez-Payá J; Bedía-Collantes M; Faraco-Atienzar I; Lissen E
Gastroenterol Hepatol; 2009; 32(6):387-94. PubMed ID: 19477553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
